Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Friday 03 January, 2014

GlaxoSmithKline PLC

Director/PDMR Shareholding

RNS Number : 8550W
GlaxoSmithKline PLC
03 January 2014
 



 

 

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

 

I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc (the Company).

 

On 31 December 2013, the Company's Non-Executive Directors were provisionally allocated the following awards over Ordinary Shares and ADSs in the Company through the annual reinvestment of dividends paid throughout 2013; calculated using an average price of £16.07 per Ordinary Share and $53.17 per ADS:

 

Non-Executive Director

Ordinary Shares

No. of ADSs

Sir Christopher Gent

4,354.409

 

Prof Sir Roy Anderson

675.908      

 

Dr Stephanie Burns

 

528.928

Stacey Cartwright

125.486

 

Lynn Elsenhans

 

62.813

Judy Lewent

 

        80.699

Sir Deryck Maughan

 

1,343.402

Dr Daniel Podolsky

 

951.863

Tom de Swaan

980.751

 

Jing Ulrich

 

19.485

Hans Wijers

3.631

 

Sir Robert Wilson

1,485.756

 

 

The Company and the Non-Executive Directors were informed of these allocations on 2 January 2014.

 

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

 

Sonja Arsenić 

Corporate Secretariat

3 January 2014

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSKXLBBZFFXBBK

a d v e r t i s e m e n t